aluates Reports

$ 0.0

Automative

Global Oncology Immunotherapy Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-9T10240

Global Oncology Immunotherapy Market Insights Forecast to 2028

BUY CHAPTERS

Global Oncology Immunotherapy Market Research Report 2025

Code: QYRE-Auto-9T10240

Report

July 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bristol–Myers Squibb

Merck

Roche

Astrazeneca plc

Sanofi

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc

Merck KGaA

Oncology Immunotherapy Market Size

The global market for Oncology Immunotherapy was valued at US$ 2541 million in the year 2024 and is projected to reach a revised size of US$ 4395 million by 2031, growing at a CAGR of 8.3% during the forecast period.

Oncology Immunotherapy Market

Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body"s own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.

The Oncology Immunotherapy market has expanded as a groundbreaking approach to treating cancer by harnessing the body"s immune system to target and fight cancer cells. This innovative therapy includes immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines, among others. By enhancing the immune response against tumors, immunotherapy offers potentially durable and targeted treatments, often with fewer side effects compared to traditional approaches. The market"s growth is driven by promising clinical outcomes and a growing understanding of immune-tumor interactions. As researchers continue to explore and refine immunotherapeutic strategies, the Oncology Immunotherapy market remains at the forefront of oncology, revolutionizing cancer treatment paradigms and offering new hope to patients.

This report aims to provide a comprehensive presentation of the global market for Oncology Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Immunotherapy.

The Oncology Immunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncology Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oncology Immunotherapy Market Report

Report Metric	Details
Report Name	Oncology Immunotherapy Market
Accounted market size in year	US$ 2541 million
Forecasted market size in 2031	US$ 4395 million
CAGR	8.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Immune Checkpoint Inhibitors Cytokine-Based Immunotherapy Cancer Vaccines CAR-T Cell Therapy Other
Segment by Application	Hospitals Drugstores Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bristol-Myers Squibb, Merck & Co, Roche AG, AstraZeneca, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Immunotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oncology Immunotherapy Market growing?

Ans: The Oncology Immunotherapy Market witnessing a CAGR of 8.3% during the forecast period 2025-2031.

What is the Oncology Immunotherapy Market size in 2031?

Ans: The Oncology Immunotherapy Market size in 2031 will be US$ 4395 million.

Who are the main players in the Oncology Immunotherapy Market report?

Ans: The main players in the Oncology Immunotherapy Market are Bristol-Myers Squibb, Merck & Co, Roche AG, AstraZeneca, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA

What are the Application segmentation covered in the Oncology Immunotherapy Market report?

Ans: The Applications covered in the Oncology Immunotherapy Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Oncology Immunotherapy Market report?

Ans: The Types covered in the Oncology Immunotherapy Market report are Immune Checkpoint Inhibitors, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, Other

Recommended Reports

Cancer Immunotherapy Markets

Cell-Based Therapy

Cancer Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oncology Immunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Immune Checkpoint Inhibitors

1.2.3 Cytokine-Based Immunotherapy

1.2.4 Cancer Vaccines

1.2.5 CAR-T Cell Therapy

1.2.6 Other

1.3 Market by Application

1.3.1 Global Oncology Immunotherapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Drugstores

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oncology Immunotherapy Market Perspective (2020-2031)

2.2 Global Oncology Immunotherapy Growth Trends by Region

2.2.1 Global Oncology Immunotherapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oncology Immunotherapy Historic Market Size by Region (2020-2025)

2.2.3 Oncology Immunotherapy Forecasted Market Size by Region (2026-2031)

2.3 Oncology Immunotherapy Market Dynamics

2.3.1 Oncology Immunotherapy Industry Trends

2.3.2 Oncology Immunotherapy Market Drivers

2.3.3 Oncology Immunotherapy Market Challenges

2.3.4 Oncology Immunotherapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oncology Immunotherapy Players by Revenue

3.1.1 Global Top Oncology Immunotherapy Players by Revenue (2020-2025)

3.1.2 Global Oncology Immunotherapy Revenue Market Share by Players (2020-2025)

3.2 Global Oncology Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oncology Immunotherapy Revenue

3.4 Global Oncology Immunotherapy Market Concentration Ratio

3.4.1 Global Oncology Immunotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oncology Immunotherapy Revenue in 2024

3.5 Global Key Players of Oncology Immunotherapy Head office and Area Served

3.6 Global Key Players of Oncology Immunotherapy, Product and Application

3.7 Global Key Players of Oncology Immunotherapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Immunotherapy Breakdown Data by Type

4.1 Global Oncology Immunotherapy Historic Market Size by Type (2020-2025)

4.2 Global Oncology Immunotherapy Forecasted Market Size by Type (2026-2031)

5 Oncology Immunotherapy Breakdown Data by Application

5.1 Global Oncology Immunotherapy Historic Market Size by Application (2020-2025)

5.2 Global Oncology Immunotherapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oncology Immunotherapy Market Size (2020-2031)

6.2 North America Oncology Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oncology Immunotherapy Market Size by Country (2020-2025)

6.4 North America Oncology Immunotherapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oncology Immunotherapy Market Size (2020-2031)

7.2 Europe Oncology Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oncology Immunotherapy Market Size by Country (2020-2025)

7.4 Europe Oncology Immunotherapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oncology Immunotherapy Market Size (2020-2031)

8.2 Asia-Pacific Oncology Immunotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oncology Immunotherapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Oncology Immunotherapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oncology Immunotherapy Market Size (2020-2031)

9.2 Latin America Oncology Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oncology Immunotherapy Market Size by Country (2020-2025)

9.4 Latin America Oncology Immunotherapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oncology Immunotherapy Market Size (2020-2031)

10.2 Middle East & Africa Oncology Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oncology Immunotherapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Oncology Immunotherapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bristol-Myers Squibb

11.1.1 Bristol-Myers Squibb Company Details

11.1.2 Bristol-Myers Squibb Business Overview

11.1.3 Bristol-Myers Squibb Oncology Immunotherapy Introduction

11.1.4 Bristol-Myers Squibb Revenue in Oncology Immunotherapy Business (2020-2025)

11.1.5 Bristol-Myers Squibb Recent Development

11.2 Merck & Co

11.2.1 Merck & Co Company Details

11.2.2 Merck & Co Business Overview

11.2.3 Merck & Co Oncology Immunotherapy Introduction

11.2.4 Merck & Co Revenue in Oncology Immunotherapy Business (2020-2025)

11.2.5 Merck & Co Recent Development

11.3 Roche AG

11.3.1 Roche AG Company Details

11.3.2 Roche AG Business Overview

11.3.3 Roche AG Oncology Immunotherapy Introduction

11.3.4 Roche AG Revenue in Oncology Immunotherapy Business (2020-2025)

11.3.5 Roche AG Recent Development

11.4 AstraZeneca

11.4.1 AstraZeneca Company Details

11.4.2 AstraZeneca Business Overview

11.4.3 AstraZeneca Oncology Immunotherapy Introduction

11.4.4 AstraZeneca Revenue in Oncology Immunotherapy Business (2020-2025)

11.4.5 AstraZeneca Recent Development

11.5 Sanofi S.A.

11.5.1 Sanofi S.A. Company Details

11.5.2 Sanofi S.A. Business Overview

11.5.3 Sanofi S.A. Oncology Immunotherapy Introduction

11.5.4 Sanofi S.A. Revenue in Oncology Immunotherapy Business (2020-2025)

11.5.5 Sanofi S.A. Recent Development

11.6 Dendreon Pharmaceuticals

11.6.1 Dendreon Pharmaceuticals Company Details

11.6.2 Dendreon Pharmaceuticals Business Overview

11.6.3 Dendreon Pharmaceuticals Oncology Immunotherapy Introduction

11.6.4 Dendreon Pharmaceuticals Revenue in Oncology Immunotherapy Business (2020-2025)

11.6.5 Dendreon Pharmaceuticals Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Oncology Immunotherapy Introduction

11.7.4 Novartis Revenue in Oncology Immunotherapy Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 Gilead Sciences Inc.

11.8.1 Gilead Sciences Inc. Company Details

11.8.2 Gilead Sciences Inc. Business Overview

11.8.3 Gilead Sciences Inc. Oncology Immunotherapy Introduction

11.8.4 Gilead Sciences Inc. Revenue in Oncology Immunotherapy Business (2020-2025)

11.8.5 Gilead Sciences Inc. Recent Development

11.9 Merck KGaA

11.9.1 Merck KGaA Company Details

11.9.2 Merck KGaA Business Overview

11.9.3 Merck KGaA Oncology Immunotherapy Introduction

11.9.4 Merck KGaA Revenue in Oncology Immunotherapy Business (2020-2025)

11.9.5 Merck KGaA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bristol–Myers Squibb

Merck

Roche

Astrazeneca plc

Sanofi

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc

Merck KGaA

List of Tables

Table 1. Global Oncology Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Immune Checkpoint Inhibitors

Table 3. Key Players of Cytokine-Based Immunotherapy

Table 4. Key Players of Cancer Vaccines

Table 5. Key Players of CAR-T Cell Therapy

Table 6. Key Players of Other

Table 7. Global Oncology Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Oncology Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Oncology Immunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Oncology Immunotherapy Market Share by Region (2020-2025)

Table 11. Global Oncology Immunotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Oncology Immunotherapy Market Share by Region (2026-2031)

Table 13. Oncology Immunotherapy Market Trends

Table 14. Oncology Immunotherapy Market Drivers

Table 15. Oncology Immunotherapy Market Challenges

Table 16. Oncology Immunotherapy Market Restraints

Table 17. Global Oncology Immunotherapy Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Oncology Immunotherapy Market Share by Players (2020-2025)

Table 19. Global Top Oncology Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Immunotherapy as of 2024)

Table 20. Ranking of Global Top Oncology Immunotherapy Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Oncology Immunotherapy Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Oncology Immunotherapy, Headquarters and Area Served

Table 23. Global Key Players of Oncology Immunotherapy, Product and Application

Table 24. Global Key Players of Oncology Immunotherapy, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Oncology Immunotherapy Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Oncology Immunotherapy Revenue Market Share by Type (2020-2025)

Table 28. Global Oncology Immunotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Oncology Immunotherapy Revenue Market Share by Type (2026-2031)

Table 30. Global Oncology Immunotherapy Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Oncology Immunotherapy Revenue Market Share by Application (2020-2025)

Table 32. Global Oncology Immunotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Oncology Immunotherapy Revenue Market Share by Application (2026-2031)

Table 34. North America Oncology Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Oncology Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Oncology Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Oncology Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Oncology Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Oncology Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Oncology Immunotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Oncology Immunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Oncology Immunotherapy Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Oncology Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Oncology Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Oncology Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Oncology Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Oncology Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Oncology Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 49. Bristol-Myers Squibb Company Details

Table 50. Bristol-Myers Squibb Business Overview

Table 51. Bristol-Myers Squibb Oncology Immunotherapy Product

Table 52. Bristol-Myers Squibb Revenue in Oncology Immunotherapy Business (2020-2025) & (US$ Million)

Table 53. Bristol-Myers Squibb Recent Development

Table 54. Merck & Co Company Details

Table 55. Merck & Co Business Overview

Table 56. Merck & Co Oncology Immunotherapy Product

Table 57. Merck & Co Revenue in Oncology Immunotherapy Business (2020-2025) & (US$ Million)

Table 58. Merck & Co Recent Development

Table 59. Roche AG Company Details

Table 60. Roche AG Business Overview

Table 61. Roche AG Oncology Immunotherapy Product

Table 62. Roche AG Revenue in Oncology Immunotherapy Business (2020-2025) & (US$ Million)

Table 63. Roche AG Recent Development

Table 64. AstraZeneca Company Details

Table 65. AstraZeneca Business Overview

Table 66. AstraZeneca Oncology Immunotherapy Product

Table 67. AstraZeneca Revenue in Oncology Immunotherapy Business (2020-2025) & (US$ Million)

Table 68. AstraZeneca Recent Development

Table 69. Sanofi S.A. Company Details

Table 70. Sanofi S.A. Business Overview

Table 71. Sanofi S.A. Oncology Immunotherapy Product

Table 72. Sanofi S.A. Revenue in Oncology Immunotherapy Business (2020-2025) & (US$ Million)

Table 73. Sanofi S.A. Recent Development

Table 74. Dendreon Pharmaceuticals Company Details

Table 75. Dendreon Pharmaceuticals Business Overview

Table 76. Dendreon Pharmaceuticals Oncology Immunotherapy Product

Table 77. Dendreon Pharmaceuticals Revenue in Oncology Immunotherapy Business (2020-2025) & (US$ Million)

Table 78. Dendreon Pharmaceuticals Recent Development

Table 79. Novartis Company Details

Table 80. Novartis Business Overview

Table 81. Novartis Oncology Immunotherapy Product

Table 82. Novartis Revenue in Oncology Immunotherapy Business (2020-2025) & (US$ Million)

Table 83. Novartis Recent Development

Table 84. Gilead Sciences Inc. Company Details

Table 85. Gilead Sciences Inc. Business Overview

Table 86. Gilead Sciences Inc. Oncology Immunotherapy Product

Table 87. Gilead Sciences Inc. Revenue in Oncology Immunotherapy Business (2020-2025) & (US$ Million)

Table 88. Gilead Sciences Inc. Recent Development

Table 89. Merck KGaA Company Details

Table 90. Merck KGaA Business Overview

Table 91. Merck KGaA Oncology Immunotherapy Product

Table 92. Merck KGaA Revenue in Oncology Immunotherapy Business (2020-2025) & (US$ Million)

Table 93. Merck KGaA Recent Development

Table 94. Research Programs/Design for This Report

Table 95. Key Data Information from Secondary Sources

Table 96. Key Data Information from Primary Sources

Table 97. Authors List of This Report

List of Figures

Figure 1. Oncology Immunotherapy Picture

Figure 2. Global Oncology Immunotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oncology Immunotherapy Market Share by Type: 2024 VS 2031

Figure 4. Immune Checkpoint Inhibitors Features

Figure 5. Cytokine-Based Immunotherapy Features

Figure 6. Cancer Vaccines Features

Figure 7. CAR-T Cell Therapy Features

Figure 8. Other Features

Figure 9. Global Oncology Immunotherapy Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Oncology Immunotherapy Market Share by Application: 2024 VS 2031

Figure 11. Hospitals Case Studies

Figure 12. Drugstores Case Studies

Figure 13. Others Case Studies

Figure 14. Oncology Immunotherapy Report Years Considered

Figure 15. Global Oncology Immunotherapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Oncology Immunotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Oncology Immunotherapy Market Share by Region: 2024 VS 2031

Figure 18. Global Oncology Immunotherapy Market Share by Players in 2024

Figure 19. Global Top Oncology Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Immunotherapy as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Oncology Immunotherapy Revenue in 2024

Figure 21. North America Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Oncology Immunotherapy Market Share by Country (2020-2031)

Figure 23. United States Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Oncology Immunotherapy Market Share by Country (2020-2031)

Figure 27. Germany Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Oncology Immunotherapy Market Share by Region (2020-2031)

Figure 35. China Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Oncology Immunotherapy Market Share by Country (2020-2031)

Figure 43. Mexico Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Oncology Immunotherapy Market Share by Country (2020-2031)

Figure 47. Turkey Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Oncology Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Oncology Immunotherapy Business (2020-2025)

Figure 51. Merck & Co Revenue Growth Rate in Oncology Immunotherapy Business (2020-2025)

Figure 52. Roche AG Revenue Growth Rate in Oncology Immunotherapy Business (2020-2025)

Figure 53. AstraZeneca Revenue Growth Rate in Oncology Immunotherapy Business (2020-2025)

Figure 54. Sanofi S.A. Revenue Growth Rate in Oncology Immunotherapy Business (2020-2025)

Figure 55. Dendreon Pharmaceuticals Revenue Growth Rate in Oncology Immunotherapy Business (2020-2025)

Figure 56. Novartis Revenue Growth Rate in Oncology Immunotherapy Business (2020-2025)

Figure 57. Gilead Sciences Inc. Revenue Growth Rate in Oncology Immunotherapy Business (2020-2025)

Figure 58. Merck KGaA Revenue Growth Rate in Oncology Immunotherapy Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Oncology Immuno Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immuno Oncology Service Market Research Report 2024

Immuno oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immuno oncology Therapy Market Insights Forecast to 2030

Global Immunotherapy Drugs Market Research Report 2024

Global Cancer Immuno Personalized Medicine Market Research Report 2024

Immuno Oncology Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Immunotherapy Drugs Market Research Report 2024

Global Cancer Immunosuppressant Treatment Market Research Report 2024

Global Immunosuppressants in Cancer Therapy Market Research Report 2024

Global Immuno oncology Clinical Trials Market Research Report 2024

Cancer Immunotherapy Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immuno Oncology Assays Kit Market Insights Forecast to 2030

Global Immunotherapeutic Drugs Market Insights Forecast to 2030

Global Immuno Oncology Treatment Market Insights Forecast to 2030

Global Cancer Immunotherapies Market Insights Forecast to 2030

Global Immunocell Therapy Market Insights Forecast to 2030

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights Forecast to 2030

Global Immuno Cell Therapy Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions